CL2020002129A1 - Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular - Google Patents

Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular

Info

Publication number
CL2020002129A1
CL2020002129A1 CL2020002129A CL2020002129A CL2020002129A1 CL 2020002129 A1 CL2020002129 A1 CL 2020002129A1 CL 2020002129 A CL2020002129 A CL 2020002129A CL 2020002129 A CL2020002129 A CL 2020002129A CL 2020002129 A1 CL2020002129 A1 CL 2020002129A1
Authority
CL
Chile
Prior art keywords
granular composition
production method
dissolution property
property improvement
granular
Prior art date
Application number
CL2020002129A
Other languages
English (en)
Inventor
Rie Yamada
Toshinori Tanaka
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of CL2020002129A1 publication Critical patent/CL2020002129A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)

Abstract

Se proporciona un método de producción para una composición granular en el que se mejora la propiedad de disolución de 2–{4–[N–(5,6–difenilpiradin–2–il)–N–isopropilamino]butiloxi}–N–(metilsulfonil)acetamida. El método de producción para una composición granular incluye una etapa de moldeo por compresión de una mezcla obtenida por mezcla de 2–{4–[N–(5,6–difenilpiradin–2–il)–N–isopropilamino]butiloxi}–N–(metilsulfonil)acetamida y al menos uno o más excipientes seleccionados del grupo que consiste en un alcohol de azúcar, un almidón y un sacárido, obteniendo así un material moldeado por compresión.
CL2020002129A 2018-02-21 2020-08-18 Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular CL2020002129A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018029093 2018-02-21

Publications (1)

Publication Number Publication Date
CL2020002129A1 true CL2020002129A1 (es) 2021-02-05

Family

ID=67687749

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020002129A CL2020002129A1 (es) 2018-02-21 2020-08-18 Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular

Country Status (21)

Country Link
US (1) US20200397700A1 (es)
EP (1) EP3756670A4 (es)
JP (3) JP7430629B2 (es)
KR (1) KR20200123447A (es)
CN (1) CN112055591A (es)
AR (1) AR114399A1 (es)
AU (1) AU2019225516A1 (es)
BR (1) BR112020016230A2 (es)
CA (1) CA3091584A1 (es)
CL (1) CL2020002129A1 (es)
CO (1) CO2020011034A2 (es)
EC (1) ECSP20057951A (es)
IL (1) IL276732A (es)
MA (1) MA51913A (es)
MX (1) MX2020008695A (es)
PE (1) PE20210448A1 (es)
PH (1) PH12020551285A1 (es)
RU (1) RU2020130411A (es)
SG (1) SG11202007967YA (es)
TW (1) TW201936175A (es)
WO (1) WO2019163822A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022007207A2 (pt) * 2019-10-23 2022-07-26 Actelion Pharmaceuticals Ltd Composição farmacêutica que compreende selexipag
TWI908789B (zh) * 2020-04-10 2025-12-21 日商日本新藥股份有限公司 固形製劑及其製造方法
WO2025249407A1 (ja) * 2024-05-27 2025-12-04 日本新薬株式会社 セレキシパグ錠剤及びその製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2654197B2 (ja) * 1989-09-25 1997-09-17 三菱電機株式会社 スターリングエンジンの圧縮機駆動装置
JP2002097153A (ja) 2000-09-19 2002-04-02 Tadao Miyasaka グルタチオン含有酵母エキスを含む組成物
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
TWI316055B (es) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
DE60323055D1 (de) * 2003-05-06 2008-10-02 Gumlinck As Methode zur Herstellung von Kaugummigranulat und komprimierten Kaugummiprodukten, sowie ein Kaugummigranuliersystem
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
JP2011153075A (ja) 2008-04-04 2011-08-11 Shionogi & Co Ltd 水懸濁性を向上させた細粒剤
KR20250107951A (ko) * 2009-06-26 2025-07-14 니뽄 신야쿠 가부시키가이샤 결정
WO2014174848A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 錠剤
SI4331607T1 (sl) 2015-12-02 2025-06-30 Nippon Shinyaku Co., Ltd. Trdni farmacevtski sestavek, ki vsebuje 2-{4-[n-(5,6-difenilpirazin-2-il)-n-izopropilamino]butiloksi}-n-(metilsulfonil)acetamid
WO2017121806A1 (en) * 2016-01-15 2017-07-20 Sandoz Ag Pharmaceutical composition of selexipag

Also Published As

Publication number Publication date
IL276732A (en) 2020-09-30
EP3756670A4 (en) 2021-11-03
RU2020130411A3 (es) 2022-03-21
EP3756670A1 (en) 2020-12-30
MX2020008695A (es) 2020-09-25
PH12020551285A1 (en) 2021-05-31
ECSP20057951A (es) 2020-10-30
BR112020016230A2 (pt) 2020-12-08
SG11202007967YA (en) 2020-09-29
US20200397700A1 (en) 2020-12-24
JP7809780B2 (ja) 2026-02-02
RU2020130411A (ru) 2022-03-21
JP2023182650A (ja) 2023-12-26
TW201936175A (zh) 2019-09-16
JP7639092B2 (ja) 2025-03-04
CO2020011034A2 (es) 2020-12-10
JP7430629B2 (ja) 2024-02-13
AU2019225516A1 (en) 2020-10-08
AR114399A1 (es) 2020-09-02
JPWO2019163822A1 (ja) 2021-02-04
WO2019163822A1 (ja) 2019-08-29
PE20210448A1 (es) 2021-03-08
MA51913A (fr) 2020-12-30
JP2025024023A (ja) 2025-02-19
CN112055591A (zh) 2020-12-08
KR20200123447A (ko) 2020-10-29
CA3091584A1 (en) 2019-08-29

Similar Documents

Publication Publication Date Title
CO2020011034A2 (es) Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular
BR112019006488A2 (pt) artigos formados de materiais de base de polpa com liberação de aroma modulada
CO2020015153A2 (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos
BR112015024055A2 (pt) composição de polímero, em especial para aplicações de moldagem por injeção, processo para produzir uma composição de polímero, em especial para aplicações de moldagem por injeção, molde obtenível através de moldagem por injeção de uma composição de polímero e uso de uma moldagem por injeção
PE20011210A1 (es) Composiciones de almidon procesables por fusion
MX2017013011A (es) Copolimeros elastomericos a base de estireno funcionalizado con [bis(trihidrocarbilsilil)aminosililo] y su uso para preparacion de gomas.
MX388811B (es) Pieza moldeada para un material zeolitico hidrofobo y procedimiento para su produccion.
BR112019001528A8 (pt) novas formulações de comprimidos de cannabus e composições e métodos de produção do mesmo
BR112018070973A2 (pt) método de produção de um artigo por moldagem por injeção, uso de um compatibilizante em uma resina polimérica, e resina polimérica
BR112017010936A2 (pt) artigo de polilactida conformado e método de preparação
BR112017016004A2 (pt) ?método para produzir um produto moldado por injeção, e, uso de fibras de casca de semente de girassol?
BR112018068144A2 (pt) métodos e composições para maior produção de rna de fita dupla
AR106011A1 (es) Productos de caucho basados en un lote maestro de nbr mejorado
BR112018069325A2 (pt) composições e métodos de utilização destas em fundição com areia
BR112018006766A2 (pt) tampões autossuportantes e outras estruturas para uso em produção de plantas
MX2024003249A (es) Formas solidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h-[1,3]d ioxolo[4,5-f]indol-7-il)pirrol-2,5-diona.
BR112015027832A2 (pt) copolímeros estatísticos livres de açucar feitos pelo menos três monômeros
BR112017023508A2 (pt) processo para produção de uma composição de polímero reforçado com fibras, produto, e, uso de um tecido não tecido.
BR112017013349A2 (pt) composição termoplástica com alta fluidez no estado de fusão, processo de fabricação de um artigo compósito, artigo compósito, e, utilização de um oligômero
MX2020004621A (es) Composicion de moldeo termoplastica y articulos elaborados de la misma que tienen calidad de superficie mejorada.
CL2011000063A1 (es) Composicion solida que comprende una hormona somatotrofica, un componente polimerico biodegradable y un modificador de la liberacion; proceso para prepararla; formulacion que la comprende; y uso para promover el crecimiento, tratar y/o prevenir el retardo de crecimiento, entre otros.
RU2017130661A (ru) Сырьевая смесь для изготовления керамзита
BRPI0605332A (pt) borracha de nitrila hidrogenada com distribuição de peso molecular limitada, seu uso e processo para sua preparação
EA201992288A1 (ru) Мягкая полипропиленовая композиция с улучшенными свойствами
BR112017006651A2 (pt) composição surfactante